Take Solutions Limited (NSE: TAKE; BSE: 532890), a global domain-intensive technology company, today announced the launch of its Innovation Fund with an initial corpus commitment of Rs. 50 million (Rs. 5 crore). The fund is aimed at identifying, investing in, and scaling high-potential startups operating at the convergence of Artificial Intelligence (AI), deep technology, and the rapidly expanding health and wellness sector.
The initiative underscores Take Solutions' strategic pivot towards enabling next-generation, technologyled business models while creating long-term value for stakeholders. The Innovation Fund will focus on early- and growth-stage companies that are leveraging data, AI, and scientific innovation to transform healthcare delivery, diagnostics, and human health outcomes.
Mr. Parmeshvar Dhangare, Director, TAKE Solutions Ltd, said "The future of value creation lies at the intersection of science and scalable technology. Through the Innovation Fund, we aim to partner with visionary entrepreneurs who are solving complex global challenges. Our objective is to build a highimpact ecosystem that delivers sustainable financial returns while also improving human health outcomes.
The launch of the Innovation Fund reflects Take Solutions' commitment to diversifying its growth avenues and strengthening its position in high-margin, innovation-led sectors. By aligning capital allocation with emerging global trends in AI and healthcare, the company aims to create long-term shareholder value while participating in the evolution of the future economy."
India's health and wellness market is projected to grow to $400-500 billion over the next decade, driven by rising healthcare awareness, digital adoption, and increasing life expectancy. Against this backdrop, Take Solutions aims to position itself as a catalyst in building scalable, technology-driven solutions addressing critical gaps in healthcare access, affordability, and efficiency.
The fund's investment thesis is anchored in the belief that the convergence of biology and technology will drive the next wave of global value creation. With chronic diseases accounting for nearly 60% of deaths and a growing need to extend "healthspan," the company sees significant opportunities in AI-led diagnostics, predictive analytics, precision medicine, and digital therapeutics. These sectors are expected to witness exponential growth, driven by increasing demand for personalized, data-driven solutions and the integration of advanced technologies into traditional industries.
The Innovation Fund will go beyond financial investment by offering portfolio companies access to its global ecosystem. This includes deep domain expertise in life sciences and supply chain management, institutional partnerships across clinical and regulatory networks, and access to advanced technology infrastructure and established go-to-market channels.
This integrated approach is designed to accelerate commercialization, reduce time-to-market, and enhance scalability for portfolio companies, thereby improving the probability of success and returns.
Focused Investment Strategy:- The Innovation Fund will deploy capital across four key segments:
- AI & Data Intelligence: Supporting startups developing AI-driven diagnostics, predictive analytics platforms, and scalable SaaS solutions.
- Longevity & Bio-Convergence: Investing in cutting-edge areas such as genomics, cellular health, and age-reversal technologies.
- Digital Health Platforms: Backing companies focused on remote monitoring, wearable technologies, and real-time health data ecosystems.
- Technology Infrastructure: Enabling platforms that enhance efficiency, compliance, and scalability across knowledge-led industries.
With a disciplined investment approach and strong execution capabilities, Take Solutions is well-positioned to capitalize on the significant opportunities emerging at the intersection of technology, healthcare, and data science.